Masitinib targets mast cells, which play a critical role in severe forms of SCD and its complications, including vaso-occlusive crises, acute chest syndrome, and pain
The approval makes AQVESME the only FDA-approved therapy for anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia
BBIL will guarantee production and supply of MTBVAC to more than 70 countries across Africa and Southeast Asia
The Phase 1 study will evaluate the safety, tolerability, and pharmacokinetics (PK) of ENV-6946 in healthy volunteers
Adverse events were consistent with valbenazine’s established safety profile
Under the 2023 collaboration agreement, Assembly Bio will receive $35 million for Gilead’s exercise of the HSV program option
AFib is a progressive condition where timely intervention is critical to disease management and, ultimately, the patient's quality of life
The trial will evaluate the efficacy and safety of IPX203 versus immediate-release levodopa/carbidopa
Wegovy pill showed a mean weight loss of 16.6% in the OASIS 4 trial
The study focused on patients without actionable genomic alterations whose disease had progressed after prior immunotherapy and platinum-based chemotherapy
Subscribe To Our Newsletter & Stay Updated
